Skip to the page

Data / Form D filings / Tamarind Bio, Inc.

Tamarind Bio, Inc.: Form D filing

Tamarind Bio, Inc., a technology company in San Francisco, CA, filed a Form D with the SEC in 2025. The latest, on May 15, 2025, reports $13.6 million sold of a $13.6 million offering to 24 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2325 3RD STREET, STE 320, San Francisco, CA, 94107
Phone
(707) 361-9565
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2068537

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 15, 2025New notice$13,559,984$13,559,98424May 2, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
SHERRY LIUExecutive Officer, Director
DENIZ KAVIExecutive Officer, Director

Other technology companies in California that filed recently

Every Form D from the week of May 12, 2025 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Tamarind Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.